These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1687637)

  • 1. Analysis of proteins and lipopolysaccharides from Chinese isolates of Coxiella burnetii with monoclonal antibodies.
    Wen BH; Yu SR; Yu GQ; Li QJ; Zhang X
    Acta Virol; 1991 Nov; 35(6):538-44. PubMed ID: 1687637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of cloned variants of Coxiella burnetii isolated in China.
    Ning Z; Yu SR; Quan YG; Xue Z
    Acta Virol; 1992 Mar; 36(2):173-83. PubMed ID: 1359769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxiella burnetii phase I and II proteins studied by SDS-page.
    Lukácová M; Kazár J; Gajdosová E
    Acta Virol; 1994 Oct; 38(5):263-7. PubMed ID: 7726000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody based differentiation of Coxiella burnetii isolates.
    Sekeyová Z; Thiele D; Krauss H; Karo M; Kazár J
    Acta Virol; 1996 Jun; 40(3):127-32. PubMed ID: 8891091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved method of isolation of Coxiella burnetii proteins.
    Lukácová M; Kazár J
    Acta Virol; 1996 Feb; 40(1):55-8. PubMed ID: 8886100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological consequences of Coxiella burnetii phase variation.
    Quevedo Diaz MA; Lukácová M
    Acta Virol; 1998 Jun; 42(3):181-5. PubMed ID: 9842448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of Coxiella burnetii strains and isolates using monoclonal antibodies.
    Sekeyová Z; Kovácová E
    Ann N Y Acad Sci; 2006 Oct; 1078():557-60. PubMed ID: 17114776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase variation of lipopolysaccharide of Coxiella burnetii, strain Priscilla during chick embryo yolk sac passaging.
    Lukácová M; Kazár J; Gajdosová E; Vavreková M
    FEMS Microbiol Lett; 1993 Nov; 113(3):285-9. PubMed ID: 8270193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide.
    Ftácek P; Skultéty L; Toman R
    J Endotoxin Res; 2000; 6(5):369-76. PubMed ID: 11521057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the structural heterogeneity of the polysaccharide component of Coxiella burnetii strain Nine Mile lipopolysaccharide.
    Toman R; Kazár J
    Acta Virol; 1991 Nov; 35(6):531-7. PubMed ID: 1687636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of various methods of lipopolysaccharide isolation from Coxiella burnetii strain Priscilla in the virulent phase I.
    Skultéty L; Toman R
    Acta Virol; 1994 Aug; 38(4):209-13. PubMed ID: 7879711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic characteristic of the lipopolysaccharides of Coxiella burnetii isolates.
    To H; Hotta A; Yamaguchi T; Fukushi H; Hirai K
    J Vet Med Sci; 1998 Feb; 60(2):267-70. PubMed ID: 9524957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the 3-deoxy-D-manno-2-octulosonic acid region in a lipopolysaccharide isolated from Coxiella burnetii strain Nine Mile in phase II.
    Toman R; Skultéty L
    Acta Virol; 1994 Aug; 38(4):241-3. PubMed ID: 7879717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of protein and lipopolysaccharide patterns of several Coxiella burnetii strains in phase I.
    Novák M; Brezina R
    Acta Virol; 1989 Mar; 33(2):172-6. PubMed ID: 2569814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of specificity of interaction between synthetic key saccharide components of lipopolysaccharides and monoclonal antibodies to Coxiella burnetii.
    Kovácová E; Cmarko D; Mucha V; Toman R; Ciampor F; Kosma P; Tyczka J; Sekeyová Z
    Acta Virol; 2005; 49(4):261-70. PubMed ID: 16402683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the O-antigen biosynthesis regions of phase II isolates of Coxiella burnetii.
    Denison AM; Massung RF; Thompson HA
    FEMS Microbiol Lett; 2007 Feb; 267(1):102-7. PubMed ID: 17156123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic heterogeneity of lipopolysaccharide among Burkholderia pseudomallei clinical isolates.
    Anuntagool N; Aramsri P; Panichakul T; Wuthiekanun VR; Kinoshita R; White NJ; Sirisinha S
    Southeast Asian J Trop Med Public Health; 2000; 31 Suppl 1():146-52. PubMed ID: 11414445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the determination of "Kdo-like substance" in the lipopolysaccharide from Coxiella burnetii strain nine mile in phase II.
    Toman R; Skultéty L; Kazár J
    Acta Virol; 1993; 37(2-3):196-8. PubMed ID: 8105667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of whole cell lysate from the intercellular bacterium Coxiella burnetii using two gel-based protein separation techniques.
    Samoilis G; Psaroulaki A; Vougas K; Tselentis Y; Tsiotis G
    J Proteome Res; 2007 Aug; 6(8):3032-41. PubMed ID: 17602512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical characterization of Bacteroides vulgatus cell-surface antigens.
    Rouyan GS; Kaca W; Meisel-Mikołajczyk F
    Acta Microbiol Pol; 1998; 47(1):55-63. PubMed ID: 9691430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.